Romero-Muñoz L M, Barriga-Martín A, DeJuan-García J
Servicio de Cirugía Ortopédica y Traumatología, Hospital Nacional de Parapléjicos, Toledo, España.
Servicio de Cirugía Ortopédica y Traumatología, Hospital Nacional de Parapléjicos, Toledo, España.
Rev Esp Cir Ortop Traumatol (Engl Ed). 2018 Nov-Dec;62(6):458-466. doi: 10.1016/j.recot.2018.01.003. Epub 2018 Feb 22.
To expose our experience in the diagnostic and surgical treatment of neurogenic heterotopic ossification of the hip.
We designed an observational retrospective descriptive study including 20 patients (30 hips) with neurogenic heterotopic ossification of the hip secondary to spinal cord injury attended in our institution in the last 10 years, with a minimum of one year follow-up. Medical files and imaging studies were reviewed. The study variables analyzed were: type and localization of neurogenic heterotopic ossification, pre-post excision range of motion, level and aetiology of spinal cord injury, ASIA score, smoking history, surgical approach and complications associated with surgery.
A total of 20 patients were treated with resection of heterotopic ossification in 30 hips. 16 patients presented ASIA A spinal cord injury and 4 ASIA B spinal cord injury. Preoperatively all the patients had severe ankylosis in the hip that made sitting in a wheel chair and activities such as repositioning and hygiene difficult. The average postoperative motion at the follow-up evaluation was 90° in flexion, 20° of internal rotation and 40° of external rotation. Immediately after surgery all the patients followed a specific intensive physiotherapy regime for the hip and celecoxib 200 mg was administrated daily orally for a month to prevent recurrence of heterotopic bone formation. None of the patients reviewed suffered a recurrence of heterotopic bone formation.
Surgical excision of hip ossification in order to achieve functional ROM of the hip is the best treatment for patients with neurogenic heterotopic ossification of the hip.
阐述我们在髋部神经源性异位骨化诊断及手术治疗方面的经验。
我们设计了一项观察性回顾性描述性研究,纳入过去10年在我院就诊的20例(30髋)继发于脊髓损伤的髋部神经源性异位骨化患者,随访至少1年。查阅病历及影像学检查资料。分析的研究变量包括:神经源性异位骨化的类型和部位、切除前后的活动范围、脊髓损伤的水平及病因、美国脊髓损伤协会(ASIA)评分、吸烟史、手术入路以及与手术相关的并发症。
共20例患者的30髋接受了异位骨化切除术。16例患者为ASIA A级脊髓损伤,4例为ASIA B级脊髓损伤。术前所有患者髋部均有严重强直,导致坐轮椅困难,以及翻身和个人卫生等活动受限。随访评估时术后平均活动度为屈曲90°、内旋20°、外旋40°。术后所有患者立即接受针对髋部的特定强化物理治疗方案,并口服塞来昔布200 mg,每日1次,共1个月,以预防异位骨形成复发。所有接受复查的患者均未出现异位骨形成复发。
对于髋部神经源性异位骨化患者,手术切除髋部骨化以实现髋部功能性活动范围是最佳治疗方法。